Eli Lilly bets on eye care with buyout of gene therapy developer Adverum – Reuters

  1. Eli Lilly bets on eye care with buyout of gene therapy developer Adverum  Reuters
  2. Lilly to Acquire Adverum Biotechnologies  PR Newswire
  3. ADVM Stock Alert: Halper Sadeh LLC Is Investigating Whether  GlobeNewswire
  4. Inside Eli Lilly’s $300 Million Bet: How Obesity Billions Are Fueling a One-Shot Cure for Blindness  CTOL Digital Solutions
  5. Shareholder Alert: The Ademi Firm investigates whether Adverum Biotechnologies, Inc. is obtaining a Fair Price for its Public Shareholders  Morningstar

Continue Reading